Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide
- PMID: 25043204
- DOI: 10.1002/ana.24217
Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide
Abstract
Objective: Although astrocytes participate in glial scar formation and tissue repair, dysregulation of the NFκB pathway and of nitric oxide (NO) production in these glia cells contributes to neuroinflammation and neurodegeneration. Here we investigated the role of the crosstalk between sphingosine-1-phosphate (S1P) and cytokine signaling cascades in astrocyte activation and inflammation-mediated neurodegeneration, and addressed the effects of fingolimod on astrocyte-neuron interaction and NO synthesis in vivo. VSports手机版.
Methods: Immunohistochemistry, immunofluorescence, and confocal microscopy were used to detect S1P receptors, interleukin (IL) 1R, IL17RA, and nitrosative stress in multiple sclerosis (MS) plaques, experimental autoimmune encephalomyelitis (EAE) spinal cord, and the spinal cord of fingolimod-treated EAE mice. An in vitro model was established to study the effects of S1P, IL1, and IL17 stimulation on NFkB translocation and NO production in astrocytes, on spinal neuron survival, and on astrocyte-neuron interaction V体育安卓版. Furthermore, fingolimod efficacy in blocking astrocyte-mediated neurodegeneration was evaluated. .
Results: We found coordinated upregulation of IL1R, IL17RA, S1P1, and S1P3 together with nitrosative markers in astrocytes within MS and EAE lesions V体育ios版. In vitro studies revealed that S1P, IL17, and IL1 induced NFκB translocation and NO production in astrocytes, and astrocyte conditioned media triggered neuronal death. Importantly, fingolimod blocked the 2 activation events evoked in astrocytes by either S1P or inflammatory cytokines, resulting in inhibition of astrocyte-mediated neurodegeneration. Finally, therapeutic administration of fingolimod to EAE mice hampered astrocyte activation and NO production. .
Interpretation: A neuroprotective effect of fingolimod in vivo may result from its inhibitory action on key astrocyte activation steps VSports最新版本. .
© 2014 American Neurological Association V体育平台登录. .
"VSports手机版" Publication types
V体育平台登录 - MeSH terms
- VSports注册入口 - Actions
- V体育ios版 - Actions
- "V体育2025版" Actions
- V体育官网入口 - Actions
- Actions (V体育ios版)
- Actions (VSports在线直播)
- Actions (V体育ios版)
- VSports手机版 - Actions
- Actions (VSports在线直播)
- "V体育平台登录" Actions
- Actions (V体育ios版)
- VSports - Actions
- VSports注册入口 - Actions
- Actions (V体育2025版)
- "V体育安卓版" Actions
- Actions (V体育安卓版)
- "V体育ios版" Actions
- "V体育官网" Actions
- V体育官网入口 - Actions
- Actions (V体育安卓版)
"V体育官网" Substances
- V体育2025版 - Actions
- "V体育平台登录" Actions
- "VSports在线直播" Actions
- Actions (VSports在线直播)
- VSports app下载 - Actions
- Actions (V体育2025版)
- Actions (V体育ios版)
- VSports在线直播 - Actions
V体育2025版 - LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical